Latest Industry Insights

This article spotlights the driving forces behind Basel’s snowballing reputation, and notes some of the success stories arising from this innovative biotech powerhouse.

In this interview, Sebastian Selzer discusses the advantages of cell culture in stirred-tank bioreactors.

This article discusses the importance of data lineage and traceability for academic labs looking to maximize their publishing potential.

In this article, we explore how equipment, laboratory and experimental approaches can accelerate failure so companies change and adjust their approach before it’s too late.

To learn more about cell and gene therapy and some of the challenges facing the industry and the benefits that automation can bring, Technology Networks spoke with Nirupama Pike PhD, senior director of technical affairs at Thermo Fisher Scientific.

This article discusses how specialized charge detection mass spectrometers have been developed to enable simultaneous charge detection and decipher large and complex macromolecules, ultimately increasing accuracy and providing high-resolution measurements for better analysis of biotherapeutics.

Technology Networks connected with Dr. Kyle Luttgeharm, product manager at Agilent, head of his talk for the Technology Networks online symposium: Vaccine Research and Development 2022.

In this interview, we hear from Dr. Eliza Small about the current challenges facing RNA therapeutic development and how these challenges can be overcome.

Technology Networks spoke to Conor McKechnie, to learn more about the Biopharma Resilience Index and the changes required to get new therapeutics to market quicker.

Technology Networks recently had the pleasure of speaking with Mark Fidock, vice president for Diagnostic Development, Precision Medicine at AstraZeneca, to find out how the company is “rising to the challenge” of delivering precision medicines for chronic diseases.